Suppression of Wnt/β-Catenin Signaling Is Associated with Downregulation of Wnt1, PORCN, and Rspo2 in Alzheimer’s Disease is a research paper published in Molecular Neurobiology (2022). On theSindex it has a DataRank of 0. It has been cited 22 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH
Grant: R21AG065653
NIH
Grant: U19AG069701
Florida Department of State
Grant: 9AZ09
National Institutes of Health
Grant: 1R21AG065653-01A1
Novel Wnt activators for Alzheimer's disease therapy
National Institutes of Health
Grant: 1U19AG069701-01
Biology and pathobiology of apoE in aging and Alzheimer's disease
FWCI
1.76
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Additional file 1 of APOE deficiency impacts neural differentiation and cholesterol biosynthesis in human iPSC-derived cerebral organoids
Additional file 1 of APOE deficiency impacts neural differentiation and cholesterol biosynthesis in human iPSC-derived cerebral organoids